What a Meta-Analysis Reveals About Cone-Beam CT for Diagnosing Acute Intracranial Hemorrhage
While cone-beam computed tomography (CBCT) demonstrated high pooled sensitivity and specificity rates for intraparenchymal hemorrhage in the systematic review, researchers noted higher false-negative rates for subarachnoid and intraventricular hemorrhages.
Based on surveys of neuro-oncologists taken before and after the use of MRI perfusion imaging and spectroscopy in patients with high-grade gliomas, researchers found the advanced imaging would have led to a greater than fivefold change in patient management in comparison to previous research.
FDA Clears AI-Powered Cardiovascular Ultrasound System from Siemens Healthineers
Offering a variety of AI features for streamlined workflow and enhanced visualization, the Acuson Origin ultrasound system also features the newly FDA-cleared AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
In a recent interview, Soroush Rais-Bahrami, M.D., discussed key findings from a post-hoc subgroup analysis of the SPOTLIGHT trial that examined the use of the PET imaging agent 18F-flotufolastat (Posluma) in African American men.
Abdominal CT Study Shows 20 Percent Reduction in Iodine Contrast with Photon Counting CT
In addition to a 20.1 percent reduction in iodine load, photon-counting CT offered higher signal-to-noise and contrast-to-noise ratios than energy-integrating detector CT in a new study.
Comparative Study Evaluates AI Products for Detecting Tuberculosis on Chest X-Rays
At a 90 percent threshold for sensitivity, Lunit’s Insight CXR and the Nexus CXR software from Nexus demonstrated the highest specificity rates for tuberculosis (TB) detection in a patient population with a high prevalence of TB and HIV.
Prostate biopsy reclassification was 2.3 times more likely with PI-RADS > 4 lesions in patients in comparison to those with PI-RADS 1-3 lesion assessments, according to new MRI research involving nearly 1,500 men with low-risk and favorable intermediate risk for prostate cancer.
External validation testing revealed a deep learning combination of breast MRI, ultrasound and clinical factors had a 10 percent higher AUC for predicting axillary lymph node metastasis than sole use of MRI- or ultrasound-based deep learning models in patients with breast cancer.
What New Computed Tomography Research Reveals About Predicting Diabetes and Cardiometabolic Risks
Automated CT-derived assessments may provide stronger stratification of diabetes and cardiometabolic risks than conventional predictive models, according to a new study of over 32,000 adults in Korea.
Can Targeted PSMA PET/CT-Guided Radiotherapy Have an Impact for Oligometastatic Prostate Cancer?
Emerging research revealed a median progression-free survival of 16.4 months and a 29-month mean freedom from a new line of systemic therapy for the use of PSMA PET/CT guided, metastasis-targeted radiotherapy for patients with oligometastatic castration-resistant PCa.
Emerging PET Imaging Agent Gets FDA’s Breakthrough Therapy Designation for Cardiac Amyloidosis
Reportedly the only imaging agent to garner a breakthrough therapy designation for cardiac amyloidosis, 124I-evuzamitide has demonstrated robust sensitivity for the condition as well as a favorable safety profile.